GlobalData on MSN

ASCO26 Podcast: an analyst rundown of the best readouts and key trends

In this episode, two oncology analysts share their insights from the ASCO show floor, while talking through the readouts that ...
Insider Monkey

H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio’s (CLYM) Budoprutug Across Clinical Tracks

Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on Climb ...
Hosted on MSN

Cynata has two shots on goal with pivotal trial readouts approaching

Cynata Therapeutics prepares for two advanced clinical trial readouts in Q2 CY26 Company’s Cymerus platform aims to overcome challenges of making efficacious mesenchymal stem cells at scale Results of ...
Seeking Alpha

Cynata Therapeutics Limited (CYYNF) Discusses Imminent Clinical Trial Readouts and Key Milestones in Osteoarthritis and Graft-versus-Host Disease Transcript

So good morning, and thank you for joining Cynata Therapeutics Investor Webinar for the December 2025 quarter. Presenting this morning will be CEO and Managing Director, Dr. Kilian Kelly, who will ...